On the recordJune 12, 2019
The bottom line is this is not the place and this won't do what the offer in support of the amendment says it is going to do, because the fact of the matter is that the DEA is the one that enforced the classification of schedule I. This bill has nothing to do with the DEA. In fact, the problem with research and the problem with the difficulty in doing research does not lie in HHS. The problem lies in the fact that it is a schedule I drug, and the appropriate way to deal with this is through an authorizing committee, as the gentleman from California suggests, with legislation that would allow more research, as has been suggested. Madam Chair, I yield 1 minute to the gentleman from Pennsylvania (Mr. Perry).
